Fly-to-bedside resource offers new hope for COVID-19 treatments

FHS
July 22, 2023
2:17 am

Millions of deaths and ongoing illnesses caused by the COVID-19 pandemic have prompted scientists to seek new ways of understanding how viruses so skillfully enter and reprogram human cells.

Abivax presents first-half 2024 financial results – Biotech Investments

EQS-News: ABIVAX / Key word(s): Half Year Results Abivax presents first-half 2024 financial results 09.09.2024 / 22:01 CET/CEST The issuer is solely responsible for the

September 10, 2024

Anvatabart opadotin by Ambrx Biopharma for Gastric Cancer: Likelihood of Approval

Anvatabart opadotin is under clinical development by Ambrx Biopharma and currently in Phase I for Gastric Cancer.

February 9, 2024

Lawyer for Convicted British Killer Nurse Says New Evidence Is Grounds for Appeal

A lawyer for convicted British killer nurse Lucy Letby said Monday that he plans to ask an appeals court to re-examine her convictions after the

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.